表紙:馬用ヘルスケアの世界市場(2021年~2028年):産業分析、規模、シェア、成長、動向、予測
市場調査レポート
商品コード
1067978

馬用ヘルスケアの世界市場(2021年~2028年):産業分析、規模、シェア、成長、動向、予測

Equine Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

出版日: | 発行: Transparency Market Research | ページ情報: 英文 244 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
馬用ヘルスケアの世界市場(2021年~2028年):産業分析、規模、シェア、成長、動向、予測
出版日: 2022年01月20日
発行: Transparency Market Research
ページ情報: 英文 244 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは世界の馬用ヘルスケア市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメントおよび地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー:世界の馬用ヘルスケア市場

第4章 市場概要

  • イントロダクション
    • 製品タイプの定義
    • 業界の進化/発展
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界の馬用ヘルスケア市場の分析と予測(2017年~2028年)
    • 市場収益予測

第5章 重要な洞察

  • 凝固障害と凝固経路:概要
  • 疫学:凝固障害
  • 規制の枠組み
  • 償還シナリオ
  • 価格分析
  • バリューチェーン分析
  • ポーターのファイブフォース分析

第6章 世界の馬用ヘルスケア市場の分析と予測:製品タイプ別

  • イントロダクションと定義
    • 主な調査結果/開発
  • 市場価値予測、製品タイプ別(2017年~2028年)
    • 薬剤
    • ワクチン
    • 医療補助飼料
  • 市場の魅力分析

第7章 世界の馬用ヘルスケア市場の分析と予測:疾患タイプ別

  • イントロダクションと定義
    • 主な調査結果/開発
  • 市場価値予測、疾患タイプ別(2017年~2028年)
    • ウエストナイルウイルス
    • 馬狂犬病
    • ポトマック馬熱
    • 破傷風
    • 馬インフルエンザ
    • 馬ヘルペスウイルス
    • 馬脳脊髄炎
    • その他(馬伝染性貧血)
  • 市場の魅力分析

第8章 世界の馬用ヘルスケア市場の分析と予測:流通チャネル別

  • イントロダクションと定義
    • 主な調査結果/開発
  • 市場価値予測、流通チャネル別(2017年~2028年)
    • 獣医病院と診療所
    • 小売薬局とドラッグストア
    • その他

第9章 世界の馬用ヘルスケア市場の分析と予測:地域別

  • 主な調査結果
  • 市場価値予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析

第10章 馬用ヘルスケア市場の分析と予測:北米

  • イントロダクション
    • 主な調査結果
  • 市場価値予測、製品タイプ別(2017年~2028年)
    • 薬剤
    • ワクチン
    • 医療補助飼料
  • 北米の市場価値予測、疾患タイプ別(2017年~2027年)
    • ウエストナイルウイルス
    • 馬狂犬病
    • ポトマック馬熱
    • 破傷風
    • 馬インフルエンザ
    • 馬ヘルペスウイルス
    • 馬脳脊髄炎
    • その他(馬伝染性貧血)
  • 北米の市場価値予測、流通チャネル別(2017年~2027年)
    • 獣医病院と診療所
    • 小売薬局とドラッグストア
    • その他
  • 北米の市場価値予測、国別(2017年~2027年)
    • 米国
    • カナダ
  • 北米の馬用ヘルスケア市場の魅力分析
    • 製品タイプ
    • 疾患タイプ別
    • 流通チャネル別
    • 国別

第11章 馬用ヘルスケア市場の分析と予測:欧州

第12章 馬用ヘルスケア市場の分析と予測:アジア太平洋地域

第13章 馬用ヘルスケア市場の分析と予測:ラテンアメリカ

第14章 馬用ヘルスケア市場の分析と予測:中東・アフリカ

第15章 競合情勢

  • 市場の企業:競合マトリックス(企業の層と規模別)
  • 市場シェア/ポジション分析、企業別(2020年)
  • 競争力のあるビジネス戦略
  • 企業プロファイル
    • Bayer AG (Bayer Animal Healthcare)
    • Boehringer Ingelheim
    • Ceva Sante Animale
    • Eli Lilly and Company (Elanco)
    • Merck &Co. (Merck Animal Healthcare)
    • Sanofi (Merial)
    • Purina Animal Nutrition LLC
    • Vetoquinol SA
    • Zoetis
図表

List of Table

  • Table 01: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021-2028
  • Table 02: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021-2028
  • Table 03: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021-2028
  • Table 04: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Region, 2021-2028
  • Table 05: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021-2028
  • Table 06: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021-2028
  • Table 07: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021-2028
  • Table 08: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Country, 2021-2028
  • Table 09: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021-2028
  • Table 10: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021-2028
  • Table 11: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021-2028
  • Table 12: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021-2028
  • Table 13: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021-2028
  • Table 14: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021-2028
  • Table 15: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021-2028
  • Table 16: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021-2028
  • Table 17: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021-2028
  • Table 18: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021-2028
  • Table 19: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021-2028
  • Table 20: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021-2028
  • Table 21: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2021-2028
  • Table 22: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2021-2028
  • Table 23: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2021-2028
  • Table 24: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Country/Sub-region, 2021-2028

List of Figure

  • Figure 01: Equine Healthcare Market Snapshot
  • Figure 02: Global Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2028
  • Figure 03: Market Value Share, by Product, 2020
  • Figure 04: Market Value Share, by Disease Type, 2020
  • Figure 05: Market Value Share, by Distribution Channel, 2020
  • Figure 06: Market Value Share, by Region, 2020
  • Figure 07: Global Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 08: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017-2028
  • Figure 09: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2017-2028
  • Figure 10: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Supplemental Feed, 2017-2028
  • Figure 11: Global Equine Healthcare Market Attractiveness Analysis, by Product, 2021-2028
  • Figure 12: Global Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
  • Figure 13: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by West Nile Virus, 2017-2028
  • Figure 14: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EQUINE RABIES, 2017-2028
  • Figure 15: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Potomac Horse Fever, 2017-2028
  • Figure 16: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tetanus, 2017-2028
  • Figure 17: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Influenza, 2017-2028
  • Figure 18: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Herpes Virus, 2017-2028
  • Figure 19: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equine Encephalomyelitis, 2017-2028
  • Figure 20: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others (Equine Infectious Anemia), 2017-2028
  • Figure 21: Global Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021-2028
  • Figure 22: Global Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
  • Figure 23: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals & Clinics, 2017-2028
  • Figure 24: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies & Drug Stores, 2017-2028
  • Figure 25: Global Equine Healthcare Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2028
  • Figure 26: Global Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021-2028
  • Figure 27: Global Equine Healthcare Market Value Share Analysis, by Region, 2020 and 2028
  • Figure 28: Global Equine Healthcare Market Attractiveness Analysis, by Region, 2021-2028
  • Figure 29: North America Equine Healthcare Market Size (US$ Mn) Forecast, 2021-2028
  • Figure 30: North America Equine Healthcare Market Attractiveness Analysis, by Country, 2021-2028
  • Figure 31: North America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 32: North America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
  • Figure 33: North America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
  • Figure 34: North America Equine Healthcare Market Value Share Analysis, by Country, 2020 and 2028
  • Figure 35: North America Equine Healthcare Market Attractiveness Analysis, by Product, 2021-2028
  • Figure 36: North America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021-2028
  • Figure 37: North America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021-2028
  • Figure 38: Europe Equine Healthcare Market Size (US$ Mn) Forecast, 2021-2028
  • Figure 39: Europe Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
  • Figure 40: Europe Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 41: Europe Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
  • Figure 42: Europe Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
  • Figure 43: Europe Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
  • Figure 44: Europe Equine Healthcare Market Attractiveness Analysis, by Product, 2021-2028
  • Figure 45: Europe Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021-2028
  • Figure 46: Europe Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021-2028
  • Figure 47: Asia Pacific Equine Healthcare Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017- 2028
  • Figure 48: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
  • Figure 49: Asia Pacific Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 50: Asia Pacific Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
  • Figure 51: Asia Pacific Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
  • Figure 52: Asia Pacific Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
  • Figure 53: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Product, 2021-2028
  • Figure 54: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021-2028
  • Figure 55: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021-2028
  • Figure 56: Latin America Equine Healthcare Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2028
  • Figure 57: Latin America Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
  • Figure 58: Latin America Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 59: Latin America Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
  • Figure 60: Latin America Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
  • Figure 61: Latin America Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
  • Figure 62: Latin America Equine Healthcare Market Attractiveness Analysis, by Product, 2021-2028
  • Figure 63: Latin America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021-2028
  • Figure 64: Latin America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021-2028
  • Figure 65: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, 2017-2028
  • Figure 66: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
  • Figure 67: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Product, 2020 and 2028
  • Figure 68: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Disease Type, 2020 and 2028
  • Figure 69: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Distribution Channel, 2020 and 2028
  • Figure 70: Middle East & Africa Equine Healthcare Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
  • Figure 71: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Product, 2021-2028
  • Figure 72: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2021-2028
  • Figure 73: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2021-2028
  • Figure 74: Global Equine Healthcare Market Share Analysis, by Company, 2020
目次
Product Code: TMRGL1603

Scope of the Report

TMR's report on the global equine healthcare market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global equine healthcare market for the period 2017-2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global equine healthcare market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' literature, annual reports, press releases, and relevant documents to understand the global equine healthcare market.

Secondary research included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global equine healthcare market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global equine healthcare market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global equine healthcare market.

The report delves into the competition landscape of the global equine healthcare market. Key players operating in the global equine healthcare market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global equine healthcare market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth of companies in the global equine healthcare market?
  • What will be the Y-o-Y growth of the global equine healthcare market between 2017 and 2028?
  • What is the influence of changing trends in technologies on the global equine healthcare market?
  • Which factors are anticipated to hamper the growth of the global equine healthcare market during the forecast period?
  • Which are the leading companies in the global equine healthcare market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global equine healthcare market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during production of the global equine healthcare market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the equine healthcare market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the equine healthcare market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global equine healthcare market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global equine healthcare market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Equine Healthcare Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Equine Healthcare Market Analysis and Forecast, 2017-2028
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Coagulation Disorders & Coagulation Pathways: Overview
  • 5.2. Epidemiology: Coagulation Disorders
  • 5.3. Regulatory Framework
  • 5.4. Reimbursement Scenario
  • 5.5. Equine Healthcare Market: Pricing Analysis
  • 5.6. Equine Healthcare Market: Value Chain Analysis
  • 5.7. Equine Healthcare Market: Porter's Five Forces Analysis

6. Global Equine Healthcare Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
    • 6.1.1. Key Findings / Developments
  • 6.2. Global Equine Healthcare Market Value Forecast, by Product Type, 2017-2028
    • 6.2.1. Drugs
      • 6.2.1.1. Anti-infectives
      • 6.2.1.2. Anti-inflammatory
      • 6.2.1.3. Parasiticides
      • 6.2.1.4. Others
    • 6.2.2. Vaccines
      • 6.2.2.1. Inactivated
      • 6.2.2.2. Live Attenuated
      • 6.2.2.3. Recombinant
      • 6.2.2.4. Others
    • 6.2.3. Medical Supplemental Feed
      • 6.2.3.1. Minerals
      • 6.2.3.2. Vitamins
      • 6.2.3.3. Protein
      • 6.2.3.4. Enzyme
      • 6.2.3.5. Others
  • 6.3. Global Equine Healthcare Market Attractiveness Analysis, by Product Type

7. Global Equine Healthcare Market Analysis and Forecast, by Disease Type

  • 7.1. Introduction & Definition
    • 7.1.1. Key Findings / Developments
  • 7.2. Global Equine Healthcare Market Value Forecast, by Disease Type, 2017-2028
    • 7.2.1. West Nile Virus
    • 7.2.2. Equine Rabies
    • 7.2.3. Potomac Horse Fever
    • 7.2.4. Tetanus
    • 7.2.5. Equine Influenza
    • 7.2.6. Equine Herpes Virus
    • 7.2.7. Equine Encephalomyelitis
    • 7.2.8. Others (equine infectious anemia)
  • 7.3. Global Equine Healthcare Market Attractiveness Analysis, by Disease Type

8. Global Equine Healthcare Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
    • 8.1.1. Key Findings / Developments
  • 8.2. Global Equine Healthcare Market Value Forecast, by Distribution Channel, 2017-2028
    • 8.2.1. Veterinary Hospitals & Clinics
    • 8.2.2. Retail Pharmacies & Drug Stores
    • 8.2.3. Others

9. Global Equine Healthcare Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Equine Healthcare Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. North America Equine Healthcare Market Attractiveness Analysis, by Region

10. North America Equine Healthcare Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
    • 10.2.1. Drugs
      • 10.2.1.1. Anti-infectives
      • 10.2.1.2. Anti-infectives
      • 10.2.1.3. Anti-inflammatory
      • 10.2.1.4. Parasiticides
      • 10.2.1.5. Others
      • 10.2.1.6. Transfer Lifts
      • 10.2.1.7. Door Openers
      • 10.2.1.8. Others
    • 10.2.2. Vaccines
      • 10.2.2.1. Inactivated
      • 10.2.2.2. Live Attenuated
      • 10.2.2.3. Recombinant
      • 10.2.2.4. Others
      • 10.2.2.5. Others
    • 10.2.3. Medical Supplemental Feed
      • 10.2.3.1. Minerals
      • 10.2.3.2. Vitamins
      • 10.2.3.3. Protein
      • 10.2.3.4. Enzyme
      • 10.2.3.5. Others
  • 10.3. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
    • 10.3.1. West Nile Virus
    • 10.3.2. Equine Rabies
    • 10.3.3. Potomac Horse Fever
    • 10.3.4. Tetanus
    • 10.3.5. Equine Influenza
    • 10.3.6. Equine Herpes Virus
    • 10.3.7. Equine Encephalomyelitis
    • 10.3.8. Others (equine infectious anemia)
  • 10.4. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 10.4.1. Veterinary Hospitals & Clinics
    • 10.4.2. Retail Pharmacies & Drug Stores
    • 10.4.3. Others
  • 10.5. North America Equine Healthcare Market Value (US$ Mn) Forecast, by Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Equine Healthcare Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Disease Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Equine Healthcare Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
    • 11.2.1. Drugs
      • 11.2.1.1. Anti-infectives
      • 11.2.1.2. Anti-infectives
      • 11.2.1.3. Anti-inflammatory
      • 11.2.1.4. Parasiticides
      • 11.2.1.5. Others
      • 11.2.1.6. Transfer Lifts
      • 11.2.1.7. Door Openers
      • 11.2.1.8. Others
    • 11.2.2. Vaccines
      • 11.2.2.1. Inactivated
      • 11.2.2.2. Live Attenuated
      • 11.2.2.3. Recombinant
      • 11.2.2.4. Others
      • 11.2.2.5. Others
    • 11.2.3. Medical Supplemental Feed
      • 11.2.3.1. Minerals
      • 11.2.3.2. Vitamins
      • 11.2.3.3. Protein
      • 11.2.3.4. Enzyme
      • 11.2.3.5. Others
  • 11.3. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
    • 11.3.1. West Nile Virus
    • 11.3.2. Equine Rabies
    • 11.3.3. Potomac Horse Fever
    • 11.3.4. Tetanus
    • 11.3.5. Equine Influenza
    • 11.3.6. Equine Herpes Virus
    • 11.3.7. Equine Encephalomyelitis
    • 11.3.8. Others (Equine Infectious Anemia)
  • 11.4. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 11.4.1. Veterinary Hospitals & Clinics
    • 11.4.2. Retail Pharmacies & Drug Stores
    • 11.4.3. Others
  • 11.5. Europe Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Equine Healthcare Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Disease Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Equine Healthcare Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
    • 12.2.1. Drugs
      • 12.2.1.1. Anti-infectives
      • 12.2.1.2. Anti-infectives
      • 12.2.1.3. Anti-inflammatory
      • 12.2.1.4. Parasiticides
      • 12.2.1.5. Others
      • 12.2.1.6. Transfer Lifts
      • 12.2.1.7. Door Openers
      • 12.2.1.8. Others
    • 12.2.2. Vaccines
      • 12.2.2.1. Inactivated
      • 12.2.2.2. Live Attenuated
      • 12.2.2.3. Recombinant
      • 12.2.2.4. Others
      • 12.2.2.5. Others
    • 12.2.3. Medical Supplemental Feed
      • 12.2.3.1. Minerals
      • 12.2.3.2. Vitamins
      • 12.2.3.3. Protein
      • 12.2.3.4. Enzyme
      • 12.2.3.5. Others
  • 12.3. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
    • 12.3.1. West Nile Virus
    • 12.3.2. Equine Rabies
    • 12.3.3. Potomac Horse Fever
    • 12.3.4. Tetanus
    • 12.3.5. Equine Influenza
    • 12.3.6. Equine Herpes Virus
    • 12.3.7. Equine Encephalomyelitis
    • 12.3.8. Others (equine infectious anemia)
  • 12.4. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 12.4.1. Veterinary Hospitals & Clinics
    • 12.4.2. Retail Pharmacies & Drug Stores
    • 12.4.3. Others
  • 12.5. Asia Pacific Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Equine Healthcare Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Disease Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Equine Healthcare Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
    • 13.2.1. Drugs
      • 13.2.1.1. Anti-infectives
      • 13.2.1.2. Anti-infectives
      • 13.2.1.3. Anti-inflammatory
      • 13.2.1.4. Parasiticides
      • 13.2.1.5. Others
      • 13.2.1.6. Transfer Lifts
      • 13.2.1.7. Door Openers
      • 13.2.1.8. Others
    • 13.2.2. Vaccines
      • 13.2.2.1. Inactivated
      • 13.2.2.2. Live Attenuated
      • 13.2.2.3. Recombinant
      • 13.2.2.4. Others
      • 13.2.2.5. Others
    • 13.2.3. Medical Supplemental Feed
      • 13.2.3.1. Minerals
      • 13.2.3.2. Vitamins
      • 13.2.3.3. Protein
      • 13.2.3.4. Enzyme
      • 13.2.3.5. Others
  • 13.3. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
    • 13.3.1. West Nile Virus
    • 13.3.2. Equine Rabies
    • 13.3.3. Potomac Horse Fever
    • 13.3.4. Tetanus
    • 13.3.5. Equine Influenza
    • 13.3.6. Equine Herpes Virus
    • 13.3.7. Equine Encephalomyelitis
    • 13.3.8. Others (equine infectious anemia)
  • 13.4. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 13.4.1. Veterinary Hospitals & Clinics
    • 13.4.2. Retail Pharmacies & Drug Stores
    • 13.4.3. Others
  • 13.5. Latin America Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America Latin America
  • 13.6. Latin America Equine Healthcare Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Disease Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Healthcare Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Equine Healthcare Market Value (US$ Bn) Forecast, by Product Type, 2017-2028
    • 14.2.1. Drugs
      • 14.2.1.1. Anti-infectives
      • 14.2.1.2. Anti-infectives
      • 14.2.1.3. Anti-inflammatory
      • 14.2.1.4. Parasiticides
      • 14.2.1.5. Others
      • 14.2.1.6. Transfer Lifts
      • 14.2.1.7. Door Openers
      • 14.2.1.8. Others
    • 14.2.2. Vaccines
      • 14.2.2.1. Inactivated
      • 14.2.2.2. Live Attenuated
      • 14.2.2.3. Recombinant
      • 14.2.2.4. Others
      • 14.2.2.5. Others
    • 14.2.3. Medical Supplemental Feed
      • 14.2.3.1. Minerals
      • 14.2.3.2. Vitamins
      • 14.2.3.3. Protein
      • 14.2.3.4. Enzyme
      • 14.2.3.5. Others
  • 14.3. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Disease Type, 2017-2027
    • 14.3.1. West Nile Virus
    • 14.3.2. Equine Rabies
    • 14.3.3. Potomac Horse Fever
    • 14.3.4. Tetanus
    • 14.3.5. Equine Influenza
    • 14.3.6. Equine Herpes Virus
    • 14.3.7. Equine Encephalomyelitis
    • 14.3.8. Others (equine infectious anemia)
  • 14.4. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2027
    • 14.4.1. Veterinary Hospitals & Clinics
    • 14.4.2. Retail Pharmacies & Drug Stores
    • 14.4.3. Others
  • 14.5. Middle East & Africa Equine Healthcare Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Equine Healthcare Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Disease Type
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share / Position Analysis, by Company, 2020
  • 15.3. Competitive Business Strategies
  • 15.4. Company Profiles
    • 15.4.1. Bayer AG (Bayer Animal Healthcare)
      • 15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.1.2. Financial Analysis
      • 15.4.1.3. Growth Strategies
      • 15.4.1.4. SWOT Analysis
    • 15.4.2. Boehringer Ingelheim
      • 15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.2.2. Financial Analysis
      • 15.4.2.3. Growth Strategies
      • 15.4.2.4. SWOT Analysis
    • 15.4.3. Ceva Sante Animale
      • 15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.3.2. Financial Analysis
      • 15.4.3.3. Growth Strategies
      • 15.4.3.4. SWOT Analysis
    • 15.4.4. Eli Lilly and Company (Elanco)
      • 15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.4.2. Financial Analysis
      • 15.4.4.3. Growth Strategies
      • 15.4.4.4. SWOT Analysis
    • 15.4.5. Equine Products U.K. Ltd.
      • 15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.5.2. Financial Analysis
      • 15.4.5.3. Growth Strategies
      • 15.4.5.4. SWOT Analysis
    • 15.4.6. Merck & Co. (Merck Animal Healthcare)
      • 15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.6.2. Financial Analysis
      • 15.4.6.3. Growth Strategies
      • 15.4.6.4. SWOT Analysis
    • 15.4.7. Sanofi (Merial)
      • 15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.7.2. Financial Analysis
      • 15.4.7.3. Growth Strategies
      • 15.4.7.4. SWOT Analysis
    • 15.4.8. Purina Animal Nutrition LLC
      • 15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.8.2. Financial Analysis
      • 15.4.8.3. Growth Strategies
      • 15.4.8.4. SWOT Analysis
    • 15.4.9. Vetoquinol S.A.
      • 15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.9.2. Financial Analysis
      • 15.4.9.3. Growth Strategies
      • 15.4.9.4. SWOT Analysis
    • 15.4.10. Zoetis
      • 15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.10.2. Financial Analysis
      • 15.4.10.3. Growth Strategies
      • 15.4.10.4. SWOT Analysis